- 3.4Impact Factor
- 4.9CiteScore
- 23 daysTime to First Decision
Special Issues
Current Oncology publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Equity-Oriented Cancer Treatment and Care
Deadline: 20 January 2027
Advanced Research on Breast Cancer Genes in Cancers
Deadline: 31 December 2026
REAL Canadian Breast Cancer Alliance Collection
Deadline: 31 December 2026
Molecular and Epidemiological Insights into Skin Cancer
Deadline: 31 December 2026
PSMA PET Use in Oncology: From Diagnosis to Implications for Different Treatment Options
Deadline: 31 December 2026
U.S. Myeloma Innovations Research Collaborative (USMIRC) Collection
Deadline: 31 December 2026
2nd Edition: Action and Impact: Prevention and Screening Strategies Contributing to the Elimination of Cervical Cancer
Deadline: 31 December 2026
Advances in Thoracic Oncology: From Surgical Innovation to Outcome Optimization
Deadline: 30 November 2026
Oncofertility and Therapeutic Modalities
Deadline: 30 November 2026
Artificial Intelligence Applications in Stereotactic Radiosurgery and Neurosurgical Oncology
Deadline: 30 November 2026
Neoadjuvant Endocrine Therapy in Breast Cancer
Deadline: 30 November 2026
Clinical Progression and Treatment Outcome of Multiple Myeloma
Deadline: 15 November 2026
of 17

